Principal Financial Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
390,174
+133,149
| +52% | +$7.1M | 0.01% | 818 |
|
|
2025
Q1 | $10.4M | Buy |
+257,025
| New | +$10.4M | 0.01% | 1237 |
|
|
2024
Q3 | – | Sell |
-9,494
| Closed | -$223K | – | 2228 |
|
|
2024
Q2 | $223K | Sell |
9,494
-4,272
| -31% | -$100K | ﹤0.01% | 2121 |
|
|
2024
Q1 | $348K | Buy |
13,766
+1,858
| +16% | +$46.9K | ﹤0.01% | 2066 |
|
|
2023
Q4 | $278K | Buy |
11,908
+183
| +2% | +$4.27K | ﹤0.01% | 2079 |
|
|
2023
Q3 | $593K | Buy |
11,725
+339
| +3% | +$17.1K | ﹤0.01% | 1917 |
|
|
2023
Q2 | $532K | Buy |
11,386
+726
| +7% | +$33.9K | ﹤0.01% | 1941 |
|
|
2023
Q1 | $408K | Buy |
10,660
+1,313
| +14% | +$50.2K | ﹤0.01% | 2021 |
|
|
2022
Q4 | $512K | Buy |
9,347
+2,287
| +32% | +$125K | ﹤0.01% | 1967 |
|
|
2022
Q3 | $241K | Buy |
+7,060
| New | +$241K | ﹤0.01% | 2152 |
|
|
2021
Q2 | – | Sell |
-7,709
| Closed | -$224K | – | 2599 |
|
|
2021
Q1 | $224K | Buy |
+7,709
| New | +$224K | ﹤0.01% | 2349 |
|